Skip to main content
TNGX logo

TNGX · Tango Therapeutics, Inc. · Executive Compensation

Track TNGX — free
$21.93 -0.78 (-3.43%)
Market Cap
$3.85B
Shares
169.46M
Volume · Nov 20 932.36K Avg daily vol (3M) 3.41M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Barbara Weber $2,823,992
Adam Crystal $1,721,080
Daniella Beckman $1,155,775
Fiscal 2024
Executive Total
Barbara Weber $6,541,200
Adam Crystal $3,777,318
Daniella Beckman $3,166,290
Douglas Barry $2,094,450
Fiscal 2023
Executive Total
Barbara Weber $3,391,059
Adam Crystal $3,110,646
Alan Huang $1,770,905
Daniella Beckman $1,522,744
Fiscal 2022
Executive Total
Barbara Weber $4,681,787
Alan Huang $1,818,901
Daniella Beckman $1,516,879
Fiscal 2021
Executive Total
Barbara Weber $11,515,974
Daniella Beckman $3,176,664
Alan Huang $2,215,657
Fiscal 2020
Executive Total
Barbara Weber $958,221
Daniella Beckman $834,374
Alan Huang $589,517

Executive changes

Person Change Filed
Barbara Weber
“Dr. Weber’s resignation was not a result of any disagreement with the Company on any matter relating to the Company’s operations, practices or policies.”
Resigned 2026-08-06
Barbara Weber
“Dr. Weber’s resignation was not a result of any disagreement with the Company on any matter relating to the Company’s operations, practices or policies.”
Terminated 2026-08-06
Robert Azelby Appointed 2026-06-23
Sung Lee Appointed 2026-05-13
Kanishka Pothula
“Mr. Pothula’s resignation was not a result of any disagreement with the Company on any matter relating to the Company’s operations, practices or policies.”
Resigned 2026-05-13
Alexis Borisy
“Mr. Borisy’s resignation was not a result of any disagreement with the Company on any matter relating to the Company’s operations, practices or policies.”
Resigned 2026-05-13
Daniella Beckman Terminated 2026-05-08
Janice Kapty Appointed 2026-04-15
Yen-Ching Chua Appointed 2026-04-15
Jessica Newcomb Appointed 2026-04-15
Matthew Gall Appointed 2026-04-15
Barbara Weber, M.D.
“Dr. Weber's resignation as President and Chief Executive Officer and transition is not the result of any disagreement with respect to the Company's operations, policies, or practices.”
Retired 2026-01-08
Malte Peters Appointed 2026-01-08
Barbara Weber
“Dr. Weber's resignation as President and Chief Executive Officer and transition is not the result of any disagreement with respect to the Company's operations, policies, or practices.”
Retired 2026-01-08
Malte Peters, M.D. Appointed 2026-01-08
Barbara Weber, M.D. Appointed 2026-01-08
Sung H. Lee Appointed 2026-01-05
Douglas Barry Resigned 2025-08-25
John Ketchum Appointed 2023-08-30
Aaron Davis
“Mr. Davis has indicated that his departure from the Board was not the result of any disagreement with management or the Board or on any matter relating to the Company’s operations, policies or practices.”
Resigned 2023-08-30
Jannik Andersen Appointed 2023-08-07
Adam Crystal, M.D., Ph.D. Appointed 2023-02-28
Barbara Weber Appointed 2021-08-13
Aaron Davis Appointed 2021-08-13
Mace Rothenberg Appointed 2021-08-13

Leadership

Key facts CIK 1819133 CUSIP 87583X109 13F (30d) 267 filings 250 filers Visit website Investor relations